RE:@ $140 MILLION RUN RATEThe x factor will be the exponential growth in the data base. If i remember correctly from the CC, we'll be going from about 70,000 patients to approximately 300,000. A good portion of the newly added customers will have additional needs to serve and the new acquisitions have new product lines we can sell to the existing database. I think Dalsin was being pretty conservative. The potential in a database that size with the amount of new products to sell is incredible. They've already upped guidance from 100 to 175 million in 4 months, it will be interesting to see what guidance is in another 4.